149 related articles for article (PubMed ID: 33370521)
1. Statin use and the overall survival of renal cell carcinoma: A meta-analysis.
Wu P; Xiang T; Wang J; Lv R; Zhuang Y; Wu G
Clin Invest Med; 2020 Dec; 43(4):E17-23. PubMed ID: 33370521
[TBL] [Abstract][Full Text] [Related]
2. Statins and renal cell carcinoma: Antitumor activity and influence on cancer risk and survival.
Santoni M; Monteiro FSM; Massari F; Abahssain H; Aurilio G; Molina-Cerrillo J; Myint ZW; Zabalza IO; Battelli N; Grande E
Crit Rev Oncol Hematol; 2022 Aug; 176():103731. PubMed ID: 35718065
[TBL] [Abstract][Full Text] [Related]
3. Statins and survival outcomes in patients with metastatic renal cell carcinoma.
McKay RR; Lin X; Albiges L; Fay AP; Kaymakcalan MD; Mickey SS; Ghoroghchian PP; Bhatt RS; Kaffenberger SD; Simantov R; Choueiri TK; Heng DY
Eur J Cancer; 2016 Jan; 52():155-62. PubMed ID: 26687834
[TBL] [Abstract][Full Text] [Related]
4. Role of Statins in Treatment and Prevention of Community-acquired Pneumonia:A Meta-analysis.
Wang ST; Sun XF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Feb; 40(1):30-40. PubMed ID: 29532779
[TBL] [Abstract][Full Text] [Related]
5. Impact of statin on renal cell carcinoma patients undergoing nephrectomy. Does it affect cancer progression and improves survival? A Systematic Review and Meta-Analysis.
Adli G; Yogiswara N; Gde Tirta Yoga Yatindra IB; Putra RM; Djatisoesanto W
Arch Ital Urol Androl; 2023 Oct; 95(3):11672. PubMed ID: 37791546
[TBL] [Abstract][Full Text] [Related]
6. The association between statin use and endometrial cancer survival outcome: A meta-analysis.
Li J; Liu R; Sun Z; Tang S; Wang L; Liu C; Zhao W; Yao Y; Sun C
Medicine (Baltimore); 2018 Nov; 97(47):e13264. PubMed ID: 30461633
[TBL] [Abstract][Full Text] [Related]
7. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
[TBL] [Abstract][Full Text] [Related]
8. The relationship between statins and breast cancer prognosis varies by statin type and exposure time: a meta-analysis.
Liu B; Yi Z; Guan X; Zeng YX; Ma F
Breast Cancer Res Treat; 2017 Jul; 164(1):1-11. PubMed ID: 28432513
[TBL] [Abstract][Full Text] [Related]
9. The association between statin medication and progression after surgery for localized renal cell carcinoma.
Hamilton RJ; Morilla D; Cabrera F; Leapman M; Chen LY; Bernstein M; Hakimi AA; Reuter VE; Russo P
J Urol; 2014 Apr; 191(4):914-9. PubMed ID: 24291547
[TBL] [Abstract][Full Text] [Related]
10. Statin use and risk of liver cancer: an update meta-analysis.
Shi M; Zheng H; Nie B; Gong W; Cui X
BMJ Open; 2014 Sep; 4(9):e005399. PubMed ID: 25227628
[TBL] [Abstract][Full Text] [Related]
11. Effect of Statins on Kidney Disease Outcomes: A Systematic Review and Meta-analysis.
Su X; Zhang L; Lv J; Wang J; Hou W; Xie X; Zhang H
Am J Kidney Dis; 2016 Jun; 67(6):881-92. PubMed ID: 26905361
[TBL] [Abstract][Full Text] [Related]
12. The Prognostic Effect of Statin Use on Urologic Cancers: An Updated Meta-Analysis of 35 Observational Studies.
Luo Y; She DL; Xiong H; Fu SJ; Yang L
Medicine (Baltimore); 2015 Sep; 94(36):e1523. PubMed ID: 26356727
[TBL] [Abstract][Full Text] [Related]
13. Statin use and kidney cancer outcomes: A propensity score analysis.
Nayan M; Finelli A; Jewett MAS; Juurlink DN; Austin PC; Kulkarni GS; Hamilton RJ
Urol Oncol; 2016 Nov; 34(11):487.e1-487.e6. PubMed ID: 27427224
[TBL] [Abstract][Full Text] [Related]
14. [A Meta-analysis on association between statins and colorectal cancer].
Qi JH; Wei JN; Zhang ZJ; Dong L; Zhang L; Dong L; Mao YY; Lei LJ; Hu XQ; Bai WQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Feb; 42(2):343-350. PubMed ID: 33626626
[No Abstract] [Full Text] [Related]
15. The association of statin therapy with clinicopathologic outcomes and survival among patients with localized renal cell carcinoma undergoing nephrectomy.
Viers BR; Houston Thompson R; Psutka SP; Lohse CM; Cheville JC; Leibovich BC; Tollefson MK; Boorjian SA
Urol Oncol; 2015 Sep; 33(9):388.e11-8. PubMed ID: 25700974
[TBL] [Abstract][Full Text] [Related]
16. Statin utilization improves oncologic and survival outcomes in patients with dyslipidemia and surgically treated renal cell carcinoma.
Berquist SW; Lee HJ; Hamilton Z; Bagrodia A; Hassan AE; Beksaç AT; Dufour CA; Wang S; Mehrazin R; Patterson A; Derweesh IH
Minerva Urol Nefrol; 2017 Oct; 69(5):501-508. PubMed ID: 28376607
[TBL] [Abstract][Full Text] [Related]
17. Statin use and the risk of renal cell carcinoma: national cohort study.
Chou YC; Lin CH; Wong CS; Chou WY; Chang JY; Sun CA
J Investig Med; 2020 Mar; 68(3):776-781. PubMed ID: 31822508
[TBL] [Abstract][Full Text] [Related]
18. Effect of statins on gastric cancer incidence: a meta-analysis of case control studies.
Ma Z; Wang W; Jin G; Chu P; Li H
J Cancer Res Ther; 2014; 10(4):859-65. PubMed ID: 25579519
[TBL] [Abstract][Full Text] [Related]
19. [Meta-analysis of the effects of statins on the risk of chronic liver disease and hepatocellular carcinoma].
Wei J; Lvy JH; Sun XJ; Wu XR
Zhonghua Gan Zang Bing Za Zhi; 2021 Jul; 29(7):696-701. PubMed ID: 34371542
[No Abstract] [Full Text] [Related]
20. Statins for improving renal outcomes: a meta-analysis.
Sandhu S; Wiebe N; Fried LF; Tonelli M
J Am Soc Nephrol; 2006 Jul; 17(7):2006-16. PubMed ID: 16762986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
